microdosing glp 1 agonists of GLP-1's / Wellness Services / Services Microdosing GLP-1s? Here's what doctors
Description
A gut bacterial amyloid promotes -synuclein aggregation and motor impairment in mice
Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study
NICE guidance recommends annual diabetic eye screening for all people with diabetes, with the frequency of ophthalmological review potentially adjusted based on individual clinical factors such as existing retinopathy and anticipated speed of glycaemic improvement
Driven by high-profile trial data, the FDA is evaluating expanded indications, higher-dose formats, and oral daily pills
The neuroprotective effect of GLP-1 is also evident in intervention studies on neurodegenerative diseases such as Alzheimers and Parkinsons
Association of glp-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes
